AAAAAA

   
Results: 1-19 |
Results: 19
Modeling the selection of fractions during preparative HPLC of a semisynthetic pneumocandin
Authors: Oram, PD Seibert, K Leonard, W Dovletoglou, A
Citation: Pd. Oram et al., Modeling the selection of fractions during preparative HPLC of a semisynthetic pneumocandin, J LIQ CHR R, 24(6), 2001, pp. 781-798
A novel methodology for the manufacturability of robust CMOS semiconductorgas sensor arrays
Authors: Gotz, A Gracia, I Plaza, JA Cane, C Roetsch, P Bottner, H Seibert, K
Citation: A. Gotz et al., A novel methodology for the manufacturability of robust CMOS semiconductorgas sensor arrays, SENS ACTU-B, 77(1-2), 2001, pp. 395-400
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors
Authors: Walker, MC Kurumbail, RG Kiefer, JR Moreland, KT Koboldt, CM Isakson, PC Seibert, K Gierse, JK
Citation: Mc. Walker et al., A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors, BIOCHEM J, 357, 2001, pp. 709-718
Chemotherapeutic evaluation of Celecoxib, a cyclooxygeuase-2 inhibitor, ina rat mammary tumor model
Authors: Alshafie, GA Abou-Issa, HM Seibert, K Harris, RE
Citation: Ga. Alshafie et al., Chemotherapeutic evaluation of Celecoxib, a cyclooxygeuase-2 inhibitor, ina rat mammary tumor model, ONCOL REP, 7(6), 2000, pp. 1377-1381
Applications of periodically structured surfaces on glass
Authors: Wittwer, V Gombert, A Rose, K Lobmann, P Sporn, D Manns, P Doll, W Konz, W Seibert, K
Citation: V. Wittwer et al., Applications of periodically structured surfaces on glass, GL SCI T-GL, 73(4), 2000, pp. 116-118
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration
Authors: Talley, JJ Bertenshaw, SR Brown, DL Carter, JS Graneto, MJ Kellogg, MS Koboldt, CM Yuan, JH Zhang, YY Seibert, K
Citation: Jj. Talley et al., N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration, J MED CHEM, 43(9), 2000, pp. 1661-1663
4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
Authors: Talley, JJ Brown, DL Carter, JS Graneto, MJ Koboldt, CM Masferrer, JL Perkins, WE Rogers, RS Shaffer, AF Zhang, YY Zweifel, BS Seibert, K
Citation: Jj. Talley et al., 4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2, J MED CHEM, 43(5), 2000, pp. 775-777
Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents
Authors: Khanna, IK Yu, Y Huff, RM Weier, RM Xu, XD Koszyk, FJ Collins, PW Cogburn, JN Isakson, PC Koboldt, CM Masferrer, JL Perkins, WE Seibert, K Veenhuizen, AW Yuan, JH Yang, DC Zhang, YY
Citation: Ik. Khanna et al., Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents, J MED CHEM, 43(16), 2000, pp. 3168-3185
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor
Authors: Harris, RE Alshafie, GA Abou-Issa, H Seibert, K
Citation: Re. Harris et al., Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor, CANCER RES, 60(8), 2000, pp. 2101-2103
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
Authors: Masferrer, JL Leahy, KM Koki, AT Zweifel, BS Settle, SL Woerner, BM Edwards, DA Flickinger, AG Moore, RJ Seibert, K
Citation: Jl. Masferrer et al., Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, CANCER RES, 60(5), 2000, pp. 1306-1311
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
Authors: Grubbs, CJ Lubet, RA Koki, AT Leahy, KM Masferrer, JL Steele, VE Kelloff, GJ Hill, DL Seibert, K
Citation: Cj. Grubbs et al., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats, CANCER RES, 60(20), 2000, pp. 5599-5602
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
Authors: Reddy, BS Hirose, Y Lubet, R Steele, V Kelloff, G Paulson, S Seibert, K Rao, CV
Citation: Bs. Reddy et al., Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis, CANCER RES, 60(2), 2000, pp. 293-297
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis
Authors: Jacoby, RF Seibert, K Cole, CE Kelloff, G Lubet, RA
Citation: Rf. Jacoby et al., The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis, CANCER RES, 60(18), 2000, pp. 5040-5044
COX-2 inhibitors - Is there cause for concern?
Authors: Seibert, K Lefkowith, J Tripp, C Isakson, P Needleman, P
Citation: K. Seibert et al., COX-2 inhibitors - Is there cause for concern?, NAT MED, 5(6), 1999, pp. 621-622
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors
Authors: Carter, JS Rogier, DJ Graneto, MJ Seibert, K Koboldt, CM Zhang, Y Talley, JJ
Citation: Js. Carter et al., Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors, BIOORG MED, 9(8), 1999, pp. 1167-1170
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors
Authors: Carter, JS Kramer, S Talley, JJ Penning, T Collins, P Graneto, MJ Seibert, K Koboldt, CM Masferrer, J Zweifel, B
Citation: Js. Carter et al., Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors, BIOORG MED, 9(8), 1999, pp. 1171-1174
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
Authors: Fischer, SM Lo, HH Gordon, GB Seibert, K Kelloff, G Lubet, RA Conti, CJ
Citation: Sm. Fischer et al., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis, MOL CARCINO, 25(4), 1999, pp. 231-240
Kinetic basis for selective inhibition of cyclo-oxygenases
Authors: Gierse, JK Koboldt, CM Walker, MC Seibert, K Isakson, PC
Citation: Jk. Gierse et al., Kinetic basis for selective inhibition of cyclo-oxygenases, BIOCHEM J, 339, 1999, pp. 607-614
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
Authors: Talley, JJ Bertenshaw, SR Brown, DL Carter, JS Graneto, MJ Koboldt, CM Masferrer, JL Norman, BH Rogier, DJ Zweifel, BS Seibert, K
Citation: Jj. Talley et al., 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2), MED RES REV, 19(3), 1999, pp. 199-208
Risultati: 1-19 |